eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:14
eXoZymes Shareholders Equity (Quarterly) : 3.654M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.654M |
| March 31, 2026 | 1.528M |
| December 31, 2025 | 3.397M |
| September 30, 2025 | 5.374M |
| June 30, 2025 | 7.236M |
| March 31, 2025 | 8.882M |
| Date | Value |
|---|---|
| December 31, 2024 | 10.42M |
| September 30, 2024 | -3.601M |
| June 30, 2024 | |
| December 31, 2023 | -0.3843M |
| December 31, 2022 | 1.372M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 211.08M |
| ABVC BioPharma, Inc. | 10.29M |
| Endonovo Therapeutics, Inc. | -30.05M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.982M |
| Total Liabilities (Quarterly) | 4.328M |
| Debt to Equity Ratio | 0.2969 |
| Current Ratio | 3.813 |
| Net Debt Paydown Yield | 0.06% |